drugset
drugset / Trial / NCT07167550

The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke

NCT07167550 ↗

Phase 3 Recruiting 184 enrolled Tatchempharmpreparaty, JSC
RandomizedParallel-groupDouble-blindTreatment

Summary

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Dimephosphon® in acute ischemic stroke

Timeline

Start
2025-09-06
Primary completion
2026-01-31
Completion
2026-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dimephosphon Unknown 2 g Intravenous

Indications

ischemic stroke